Cargando…
A rationale for dedicated trials of combination therapy in heart failure
As heart failure (HF) enters a new era with high level of evidence supporting the use of individual drug therapies, we put forth a rationale for the need for dedicated investigation of the safety, tolerability, and practicalities associated with combination medical therapy. Being able to tailor ther...
Autores principales: | Blumer, Vanessa, Vaduganathan, Muthiah |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9762885/ https://www.ncbi.nlm.nih.gov/pubmed/36545233 http://dx.doi.org/10.1093/eurheartjsupp/suac116 |
Ejemplares similares
-
Representation matters: a call for inclusivity and equity in heart failure clinical trials
por: Reza, Nosheen, et al.
Publicado: (2022) -
The four pillars of HFrEF therapy: is it time to treat heart failure regardless of ejection fraction?
por: Docherty, Kieran F, et al.
Publicado: (2022) -
Heart failure with reduced ejection fraction and the intersection of cardio-renal-metabolic medicine #CaReMe
por: Marx, Nikolaus, et al.
Publicado: (2022) -
Dear colleagues: enough with the men-only author panels
por: Van Spall, Harriette G C, et al.
Publicado: (2022) -
Aiming at harmony. Comparing and contrasting International HFrEF Guidelines
por: Tomasoni, Daniela, et al.
Publicado: (2022)